Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.70590654 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.41004753 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.41004753 |
4 | response to type I interferon (GO:0034340) | 5.32760902 |
5 | type I interferon signaling pathway (GO:0060337) | 5.32661176 |
6 | cellular response to type I interferon (GO:0071357) | 5.32661176 |
7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.09590958 |
8 | response to interferon-alpha (GO:0035455) | 4.95582010 |
9 | * positive regulation of interferon-alpha production (GO:0032727) | 4.90095160 |
10 | modulation by symbiont of host immune response (GO:0052553) | 4.66554456 |
11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.66554456 |
12 | modulation by symbiont of host defense response (GO:0052031) | 4.66554456 |
13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.66554456 |
14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.66554456 |
15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.66554456 |
16 | * regulation of interferon-alpha production (GO:0032647) | 4.64539585 |
17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.42693328 |
18 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.41919114 |
19 | immunoglobulin mediated immune response (GO:0016064) | 4.10442094 |
20 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.09881901 |
21 | negative regulation of cell killing (GO:0031342) | 4.06755403 |
22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.06755403 |
23 | negative regulation of viral genome replication (GO:0045071) | 3.97322814 |
24 | response to peptidoglycan (GO:0032494) | 3.89824662 |
25 | positive regulation of type 2 immune response (GO:0002830) | 3.82890212 |
26 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.79354423 |
27 | response to interferon-beta (GO:0035456) | 3.77950819 |
28 | cellular response to interferon-alpha (GO:0035457) | 3.76924947 |
29 | regulation of RIG-I signaling pathway (GO:0039535) | 3.71519259 |
30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.62711451 |
31 | response to host immune response (GO:0052572) | 3.62711451 |
32 | regulation of viral genome replication (GO:0045069) | 3.62153080 |
33 | cellular response to exogenous dsRNA (GO:0071360) | 3.61887306 |
34 | cellular response to interferon-beta (GO:0035458) | 3.58077552 |
35 | * positive regulation of interferon-beta production (GO:0032728) | 3.57558409 |
36 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.53896677 |
37 | neutrophil activation involved in immune response (GO:0002283) | 3.53272565 |
38 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.52700663 |
39 | negative regulation of viral process (GO:0048525) | 3.43203111 |
40 | T cell migration (GO:0072678) | 3.36877321 |
41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.36350443 |
42 | regulation of type 2 immune response (GO:0002828) | 3.32301190 |
43 | response to host (GO:0075136) | 3.30739628 |
44 | response to host defenses (GO:0052200) | 3.30739628 |
45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.30739628 |
46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.30539504 |
47 | detection of external biotic stimulus (GO:0098581) | 3.29949067 |
48 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.29852565 |
49 | NIK/NF-kappaB signaling (GO:0038061) | 3.29003690 |
50 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.26986727 |
51 | germinal center formation (GO:0002467) | 3.22410002 |
52 | B cell mediated immunity (GO:0019724) | 3.21650417 |
53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.20409786 |
54 | macrophage activation involved in immune response (GO:0002281) | 3.20223073 |
55 | microglial cell activation (GO:0001774) | 3.16871872 |
56 | myeloid dendritic cell differentiation (GO:0043011) | 3.10612350 |
57 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.10425184 |
58 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.09542636 |
59 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.09523351 |
60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.08693137 |
61 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.08649857 |
62 | defense response to protozoan (GO:0042832) | 3.07610690 |
63 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.05384422 |
64 | regulation of chronic inflammatory response (GO:0002676) | 3.04922427 |
65 | macrophage activation (GO:0042116) | 3.04394533 |
66 | detection of bacterium (GO:0016045) | 3.03313764 |
67 | interferon-gamma secretion (GO:0072643) | 3.02973543 |
68 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.02437618 |
69 | defense response to virus (GO:0051607) | 3.01188583 |
70 | positive regulation of antigen processing and presentation (GO:0002579) | 3.00782130 |
71 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.99982774 |
72 | natural killer cell mediated immunity (GO:0002228) | 2.99982774 |
73 | cellular response to interferon-gamma (GO:0071346) | 2.99932831 |
74 | leukocyte aggregation (GO:0070486) | 2.98812302 |
75 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.97454149 |
76 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.95977564 |
77 | respiratory burst (GO:0045730) | 2.95296399 |
78 | regulation of response to interferon-gamma (GO:0060330) | 2.93832560 |
79 | T-helper 1 type immune response (GO:0042088) | 2.93215871 |
80 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.91607232 |
81 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91325799 |
82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.90851579 |
83 | response to muramyl dipeptide (GO:0032495) | 2.90113512 |
84 | neutrophil activation (GO:0042119) | 2.89792760 |
85 | regulation of T cell tolerance induction (GO:0002664) | 2.89587763 |
86 | lymphocyte chemotaxis (GO:0048247) | 2.89149651 |
87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.87921700 |
88 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.87919251 |
89 | detection of biotic stimulus (GO:0009595) | 2.87685015 |
90 | granulocyte activation (GO:0036230) | 2.87527950 |
91 | regulation of vitamin metabolic process (GO:0030656) | 2.87043946 |
92 | regulation of necroptotic process (GO:0060544) | 2.86391765 |
93 | interferon-gamma production (GO:0032609) | 2.85035550 |
94 | response to protozoan (GO:0001562) | 2.85032392 |
95 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.84296696 |
96 | * cellular response to virus (GO:0098586) | 2.84097731 |
97 | positive regulation of humoral immune response (GO:0002922) | 2.83719713 |
98 | regulation of interleukin-12 production (GO:0032655) | 2.83616944 |
99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.82721783 |
100 | myeloid cell activation involved in immune response (GO:0002275) | 2.82001164 |
101 | * negative regulation of type I interferon production (GO:0032480) | 2.80212011 |
102 | negative regulation of type 2 immune response (GO:0002829) | 2.78268823 |
103 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.77397901 |
104 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.76775378 |
105 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.76756983 |
106 | detection of molecule of bacterial origin (GO:0032490) | 2.75389381 |
107 | positive regulation of interleukin-12 production (GO:0032735) | 2.73361598 |
108 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.73344495 |
109 | negative regulation of defense response to virus (GO:0050687) | 2.72921002 |
110 | regulation of antigen processing and presentation (GO:0002577) | 2.71530764 |
111 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.70700835 |
112 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.70202031 |
113 | response to interferon-gamma (GO:0034341) | 2.69492486 |
114 | positive regulation of response to biotic stimulus (GO:0002833) | 2.69123224 |
115 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.67933611 |
116 | * regulation of interferon-beta production (GO:0032648) | 2.67667195 |
117 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.66080165 |
118 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.65963728 |
119 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.65858288 |
120 | I-kappaB phosphorylation (GO:0007252) | 2.62576987 |
121 | positive regulation of B cell differentiation (GO:0045579) | 2.60020128 |
122 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.59589613 |
123 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.57775607 |
124 | superoxide anion generation (GO:0042554) | 2.57489254 |
125 | regulation of chemokine biosynthetic process (GO:0045073) | 2.56162707 |
126 | detection of other organism (GO:0098543) | 2.56140170 |
127 | negative regulation of lipid storage (GO:0010888) | 2.55901880 |
128 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.55863339 |
129 | myeloid dendritic cell activation (GO:0001773) | 2.55701615 |
130 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.55654623 |
131 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.55575766 |
132 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.54219729 |
133 | negative regulation of interleukin-12 production (GO:0032695) | 2.53217839 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.72069289 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.84371425 |
3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.64271398 |
4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.95328282 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.93911964 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.26459904 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.61890451 |
8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.53548142 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17682958 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01537150 |
11 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.98629279 |
12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.96682306 |
13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.79801058 |
14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.70644225 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.66649110 |
16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.58256908 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.34344142 |
18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.28153562 |
19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25050103 |
20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.16975456 |
21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.12705429 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.10562611 |
23 | MYB_26560356_Chip-Seq_TH2_Human | 2.02146856 |
24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.90958064 |
25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.90784532 |
26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.89695770 |
27 | MYB_26560356_Chip-Seq_TH1_Human | 1.83656877 |
28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81756356 |
29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78360877 |
30 | MAF_26560356_Chip-Seq_TH1_Human | 1.77823314 |
31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75428322 |
32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70435449 |
33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62761707 |
34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61401298 |
35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57045517 |
36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55866388 |
37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55522917 |
38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53575879 |
39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43478729 |
40 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41070800 |
41 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.38657774 |
42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38161459 |
43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.36954914 |
44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33287125 |
45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32405016 |
46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28729756 |
47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27826893 |
48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26926033 |
49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26253573 |
50 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26155407 |
51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22459666 |
52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19715923 |
53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16819820 |
54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16679626 |
55 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16217652 |
56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15598794 |
57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15432474 |
58 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.13706453 |
59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08252094 |
60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06622281 |
61 | MYC_22102868_ChIP-Seq_BL_Human | 1.06042431 |
62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04672031 |
63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04476980 |
64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02894413 |
65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02179304 |
66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00303443 |
67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00227779 |
68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99794792 |
69 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99354835 |
70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99169939 |
71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98712913 |
72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97588908 |
73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96233583 |
74 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95717959 |
75 | MAF_26560356_Chip-Seq_TH2_Human | 0.95347018 |
76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94352418 |
77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93786231 |
78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91982482 |
79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90285109 |
80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88858746 |
81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87374390 |
82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86931271 |
83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86881302 |
84 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.86119764 |
85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84998550 |
86 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81571720 |
87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79880065 |
88 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79736753 |
89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79602446 |
90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78765874 |
91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78460252 |
92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78252060 |
93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78047039 |
94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.78030763 |
95 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.78030763 |
96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.77853538 |
97 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77529996 |
98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75970137 |
99 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.75211981 |
100 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.75182876 |
101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75159673 |
102 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74829025 |
103 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.74377615 |
104 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74287136 |
105 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.73495765 |
106 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72773887 |
107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71782464 |
108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71263200 |
109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71092881 |
110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.70666243 |
111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.70614017 |
112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70425884 |
113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70126232 |
114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.70078514 |
115 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.69625500 |
116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69385069 |
117 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.67219265 |
118 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.63592378 |
119 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.62326323 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.29005868 |
2 | MP0009785_altered_susceptibility_to | 3.68699320 |
3 | MP0003724_increased_susceptibility_to | 3.36249818 |
4 | MP0003436_decreased_susceptibility_to | 3.00637182 |
5 | MP0005387_immune_system_phenotype | 2.94364599 |
6 | MP0001790_abnormal_immune_system | 2.94364599 |
7 | MP0005671_abnormal_response_to | 2.83503771 |
8 | MP0000685_abnormal_immune_system | 2.79993483 |
9 | * MP0005025_abnormal_response_to | 2.76304150 |
10 | MP0005000_abnormal_immune_tolerance | 2.74788001 |
11 | MP0002148_abnormal_hypersensitivity_rea | 2.73393268 |
12 | MP0006082_CNS_inflammation | 2.69678308 |
13 | MP0001800_abnormal_humoral_immune | 2.64367881 |
14 | MP0002419_abnormal_innate_immunity | 2.59736857 |
15 | * MP0002452_abnormal_antigen_presenting | 2.48483678 |
16 | * MP0002723_abnormal_immune_serum | 2.41085167 |
17 | * MP0001819_abnormal_immune_cell | 2.19885732 |
18 | * MP0002420_abnormal_adaptive_immunity | 2.17911437 |
19 | MP0003763_abnormal_thymus_physiology | 2.14336488 |
20 | MP0002166_altered_tumor_susceptibility | 2.11967839 |
21 | MP0003303_peritoneal_inflammation | 2.07446555 |
22 | MP0002006_tumorigenesis | 2.05971278 |
23 | MP0005451_abnormal_body_composition | 2.03606918 |
24 | MP0004947_skin_inflammation | 1.89514688 |
25 | MP0005464_abnormal_platelet_physiology | 1.88514261 |
26 | MP0004510_myositis | 1.85419341 |
27 | MP0001853_heart_inflammation | 1.84825809 |
28 | * MP0010155_abnormal_intestine_physiology | 1.82650802 |
29 | MP0002405_respiratory_system_inflammati | 1.82392787 |
30 | MP0006054_spinal_hemorrhage | 1.80270850 |
31 | MP0001533_abnormal_skeleton_physiology | 1.79131803 |
32 | * MP0001845_abnormal_inflammatory_respons | 1.79063244 |
33 | MP0002332_abnormal_exercise_endurance | 1.78963441 |
34 | MP0009764_decreased_sensitivity_to | 1.77483965 |
35 | MP0008004_abnormal_stomach_pH | 1.74493415 |
36 | * MP0002398_abnormal_bone_marrow | 1.73579261 |
37 | * MP0000716_abnormal_immune_system | 1.72988956 |
38 | MP0002138_abnormal_hepatobiliary_system | 1.68151478 |
39 | * MP0008469_abnormal_protein_level | 1.67324580 |
40 | MP0003300_gastrointestinal_ulcer | 1.65819534 |
41 | MP0003191_abnormal_cellular_cholesterol | 1.62050913 |
42 | MP0008260_abnormal_autophagy | 1.56172439 |
43 | MP0005257_abnormal_intraocular_pressure | 1.54580389 |
44 | MP0005058_abnormal_lysosome_morphology | 1.49211725 |
45 | MP0001545_abnormal_hematopoietic_system | 1.48261105 |
46 | MP0005397_hematopoietic_system_phenotyp | 1.48261105 |
47 | MP0003448_altered_tumor_morphology | 1.46468577 |
48 | MP0009333_abnormal_splenocyte_physiolog | 1.46412990 |
49 | MP0009278_abnormal_bone_marrow | 1.46335163 |
50 | * MP0000689_abnormal_spleen_morphology | 1.45171102 |
51 | * MP0002429_abnormal_blood_cell | 1.41427389 |
52 | MP0004883_abnormal_blood_vessel | 1.36033588 |
53 | MP0000858_altered_metastatic_potential | 1.34295151 |
54 | * MP0002722_abnormal_immune_system | 1.33654060 |
55 | MP0002396_abnormal_hematopoietic_system | 1.30974938 |
56 | MP0000343_altered_response_to | 1.30427372 |
57 | MP0001873_stomach_inflammation | 1.29633067 |
58 | MP0004782_abnormal_surfactant_physiolog | 1.27521206 |
59 | MP0002998_abnormal_bone_remodeling | 1.24636297 |
60 | MP0009840_abnormal_foam_cell | 1.20485340 |
61 | MP0004808_abnormal_hematopoietic_stem | 1.19163476 |
62 | MP0002933_joint_inflammation | 1.18943185 |
63 | MP0003690_abnormal_glial_cell | 1.16381428 |
64 | MP0009763_increased_sensitivity_to | 1.16179046 |
65 | MP0002254_reproductive_system_inflammat | 1.14536348 |
66 | MP0000604_amyloidosis | 1.13363651 |
67 | MP0010352_gastrointestinal_tract_polyps | 1.13087107 |
68 | MP0008438_abnormal_cutaneous_collagen | 1.11930869 |
69 | MP0005310_abnormal_salivary_gland | 1.11251924 |
70 | MP0003566_abnormal_cell_adhesion | 1.07175550 |
71 | MP0000465_gastrointestinal_hemorrhage | 1.06253453 |
72 | MP0003186_abnormal_redox_activity | 1.06051106 |
73 | MP0003656_abnormal_erythrocyte_physiolo | 1.05777848 |
74 | MP0005360_urolithiasis | 1.04111560 |
75 | MP0005023_abnormal_wound_healing | 1.03289315 |
76 | MP0003221_abnormal_cardiomyocyte_apopto | 1.02856757 |
77 | MP0003453_abnormal_keratinocyte_physiol | 1.02118162 |
78 | MP0002277_abnormal_respiratory_mucosa | 1.00943411 |
79 | MP0010307_abnormal_tumor_latency | 0.96301901 |
80 | MP0000703_abnormal_thymus_morphology | 0.95887921 |
81 | MP0003172_abnormal_lysosome_physiology | 0.94680106 |
82 | MP0005390_skeleton_phenotype | 0.92298489 |
83 | MP0003828_pulmonary_edema | 0.89142674 |
84 | MP0000490_abnormal_crypts_of | 0.89016210 |
85 | MP0003183_abnormal_peptide_metabolism | 0.87665451 |
86 | MP0002139_abnormal_hepatobiliary_system | 0.84851536 |
87 | MP0001542_abnormal_bone_strength | 0.83330007 |
88 | MP0003091_abnormal_cell_migration | 0.80997519 |
89 | MP0000569_abnormal_digit_pigmentation | 0.79546472 |
90 | MP0003075_altered_response_to | 0.79100180 |
91 | MP0000609_abnormal_liver_physiology | 0.78349449 |
92 | MP0001851_eye_inflammation | 0.77615618 |
93 | MP0003806_abnormal_nucleotide_metabolis | 0.77371284 |
94 | MP0005166_decreased_susceptibility_to | 0.75681211 |
95 | MP0001958_emphysema | 0.74837412 |
96 | MP0003866_abnormal_defecation | 0.74252090 |
97 | MP0000249_abnormal_blood_vessel | 0.74219677 |
98 | MP0002136_abnormal_kidney_physiology | 0.73653528 |
99 | MP0005174_abnormal_tail_pigmentation | 0.71931217 |
100 | MP0009765_abnormal_xenobiotic_induced | 0.71366848 |
101 | MP0005164_abnormal_response_to | 0.70270486 |
102 | MP0005165_increased_susceptibility_to | 0.69993665 |
103 | MP0005319_abnormal_enzyme/_coenzyme | 0.69647269 |
104 | MP0001663_abnormal_digestive_system | 0.68378033 |
105 | MP0003045_fibrosis | 0.67455130 |
106 | MP0000371_diluted_coat_color | 0.67198650 |
107 | MP0003795_abnormal_bone_structure | 0.67126242 |
108 | MP0000767_abnormal_smooth_muscle | 0.65528550 |
109 | * MP0002019_abnormal_tumor_incidence | 0.64669221 |
110 | MP0003646_muscle_fatigue | 0.64665023 |
111 | MP0003252_abnormal_bile_duct | 0.64300557 |
112 | MP0002877_abnormal_melanocyte_morpholog | 0.63550660 |
113 | MP0005167_abnormal_blood-brain_barrier | 0.63309893 |
114 | MP0008874_decreased_physiological_sensi | 0.63264311 |
115 | MP0002132_abnormal_respiratory_system | 0.61162603 |
116 | * MP0000598_abnormal_liver_morphology | 0.59635931 |
117 | MP0003195_calcinosis | 0.58456768 |
118 | MP0001879_abnormal_lymphatic_vessel | 0.57433267 |
119 | MP0005376_homeostasis/metabolism_phenot | 0.56524645 |
120 | MP0005266_abnormal_metabolism | 0.52358955 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.42270665 |
2 | Recurrent abscess formation (HP:0002722) | 5.23367268 |
3 | Recurrent bacterial skin infections (HP:0005406) | 4.82963356 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.60035327 |
5 | Autoimmune thrombocytopenia (HP:0001973) | 4.25807287 |
6 | Myositis (HP:0100614) | 4.24802980 |
7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.23332748 |
8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.90226817 |
9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.90226817 |
10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.90226817 |
11 | Chronic otitis media (HP:0000389) | 3.80859310 |
12 | Orchitis (HP:0100796) | 3.80349379 |
13 | Recurrent fungal infections (HP:0002841) | 3.71132863 |
14 | Vasculitis (HP:0002633) | 3.63153252 |
15 | Recurrent viral infections (HP:0004429) | 3.61047201 |
16 | Abnormality of macrophages (HP:0004311) | 3.60391576 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 3.58335829 |
18 | Optic neuritis (HP:0100653) | 3.51890689 |
19 | Retrobulbar optic neuritis (HP:0100654) | 3.51890689 |
20 | Recurrent skin infections (HP:0001581) | 3.45788220 |
21 | Increased IgM level (HP:0003496) | 3.22768461 |
22 | Recurrent bronchitis (HP:0002837) | 3.20068996 |
23 | Peritonitis (HP:0002586) | 3.17703178 |
24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.15829649 |
25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.15829649 |
26 | Systemic lupus erythematosus (HP:0002725) | 3.09279527 |
27 | Gingivitis (HP:0000230) | 3.04965963 |
28 | Pustule (HP:0200039) | 2.96213171 |
29 | Gangrene (HP:0100758) | 2.95194765 |
30 | Loss of speech (HP:0002371) | 2.93425136 |
31 | Basal ganglia calcification (HP:0002135) | 2.89597881 |
32 | Gingival bleeding (HP:0000225) | 2.88930140 |
33 | Vacuolated lymphocytes (HP:0001922) | 2.88793380 |
34 | Periodontitis (HP:0000704) | 2.85166161 |
35 | Stomatitis (HP:0010280) | 2.82234047 |
36 | IgM deficiency (HP:0002850) | 2.80010644 |
37 | Interstitial pulmonary disease (HP:0006530) | 2.77652257 |
38 | Arterial thrombosis (HP:0004420) | 2.77361435 |
39 | Autoimmune hemolytic anemia (HP:0001890) | 2.73084150 |
40 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.72313278 |
41 | Keratitis (HP:0000491) | 2.72161588 |
42 | Hypergammaglobulinemia (HP:0010702) | 2.71607515 |
43 | Petechiae (HP:0000967) | 2.70230809 |
44 | Meningitis (HP:0001287) | 2.69732995 |
45 | Nasal polyposis (HP:0100582) | 2.68471181 |
46 | Abnormality of the nasal mucosa (HP:0000433) | 2.66484488 |
47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.66358023 |
48 | Obstructive lung disease (HP:0006536) | 2.66358023 |
49 | Pulmonary infiltrates (HP:0002113) | 2.64055093 |
50 | Myocardial infarction (HP:0001658) | 2.63801773 |
51 | Amyloidosis (HP:0011034) | 2.62770669 |
52 | Abnormality of T cell number (HP:0011839) | 2.60996041 |
53 | Cellulitis (HP:0100658) | 2.60089008 |
54 | Tetraparesis (HP:0002273) | 2.59846562 |
55 | Prostate neoplasm (HP:0100787) | 2.58247066 |
56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.56167253 |
57 | Joint hemorrhage (HP:0005261) | 2.55790851 |
58 | Chronic diarrhea (HP:0002028) | 2.54357269 |
59 | Spontaneous hematomas (HP:0007420) | 2.53104011 |
60 | Hemoptysis (HP:0002105) | 2.51993587 |
61 | Abnormality of T cells (HP:0002843) | 2.48075987 |
62 | Disinhibition (HP:0000734) | 2.46403742 |
63 | Abnormality of the pleura (HP:0002103) | 2.44975966 |
64 | Thrombocytosis (HP:0001894) | 2.44485712 |
65 | T lymphocytopenia (HP:0005403) | 2.44021497 |
66 | Colitis (HP:0002583) | 2.43054172 |
67 | Osteomyelitis (HP:0002754) | 2.41860807 |
68 | IgA deficiency (HP:0002720) | 2.41535669 |
69 | Hematochezia (HP:0002573) | 2.40323319 |
70 | Leukocytosis (HP:0001974) | 2.38143171 |
71 | Abnormality of T cell physiology (HP:0011840) | 2.37324632 |
72 | Dysostosis multiplex (HP:0000943) | 2.36309252 |
73 | Recurrent pneumonia (HP:0006532) | 2.35640462 |
74 | Prolonged bleeding time (HP:0003010) | 2.35528863 |
75 | Pulmonary embolism (HP:0002204) | 2.34422727 |
76 | Lymphopenia (HP:0001888) | 2.33988307 |
77 | Inflammation of the large intestine (HP:0002037) | 2.33507466 |
78 | Abnormality of the pericardium (HP:0001697) | 2.33395226 |
79 | Eosinophilia (HP:0001880) | 2.33191989 |
80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.32899812 |
81 | Keratoconjunctivitis sicca (HP:0001097) | 2.32264986 |
82 | Abnormality of the prostate (HP:0008775) | 2.31625735 |
83 | Joint swelling (HP:0001386) | 2.29798004 |
84 | Abnormality of the endocardium (HP:0004306) | 2.29425132 |
85 | Epistaxis (HP:0000421) | 2.28552578 |
86 | Porencephaly (HP:0002132) | 2.25688995 |
87 | Chest pain (HP:0100749) | 2.24512776 |
88 | Recurrent lower respiratory tract infections (HP:0002783) | 2.23308592 |
89 | Abnormality of B cell number (HP:0010975) | 2.22427383 |
90 | Abnormality of the fingertips (HP:0001211) | 2.21079350 |
91 | Agammaglobulinemia (HP:0004432) | 2.20674115 |
92 | Gastrointestinal infarctions (HP:0005244) | 2.19181405 |
93 | Anorexia (HP:0002039) | 2.17454865 |
94 | IgG deficiency (HP:0004315) | 2.17329625 |
95 | Gastrointestinal stroma tumor (HP:0100723) | 2.16768947 |
96 | Emphysema (HP:0002097) | 2.16764323 |
97 | Osteolytic defects of the hand bones (HP:0009699) | 2.16144532 |
98 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.16144532 |
99 | Urticaria (HP:0001025) | 2.14371910 |
100 | Gastrointestinal inflammation (HP:0004386) | 2.13768974 |
101 | Granulocytopenia (HP:0001913) | 2.13668883 |
102 | Glomerulopathy (HP:0100820) | 2.13132572 |
103 | Keratoconjunctivitis (HP:0001096) | 2.12784553 |
104 | Encephalitis (HP:0002383) | 2.12697734 |
105 | Episodic fever (HP:0001954) | 2.12345359 |
106 | Vertebral compression fractures (HP:0002953) | 2.11491522 |
107 | Polyneuropathy (HP:0001271) | 2.10941557 |
108 | Skin ulcer (HP:0200042) | 2.08213915 |
109 | Increased IgE level (HP:0003212) | 2.06591417 |
110 | Chronic sinusitis (HP:0011109) | 2.06420054 |
111 | Abnormality of eosinophils (HP:0001879) | 2.05787382 |
112 | Vertigo (HP:0002321) | 2.04064038 |
113 | Hemorrhage of the eye (HP:0011885) | 2.03461675 |
114 | Parakeratosis (HP:0001036) | 2.02107321 |
115 | Thick nail (HP:0001805) | 2.01020174 |
116 | Panhypogammaglobulinemia (HP:0003139) | 1.99754398 |
117 | Purpura (HP:0000979) | 1.98154468 |
118 | Esophageal varix (HP:0002040) | 1.98049566 |
119 | Increased cerebral lipofuscin (HP:0011813) | 1.98032062 |
120 | Cheilitis (HP:0100825) | 1.97792682 |
121 | Acne (HP:0001061) | 1.95799653 |
122 | Thyroiditis (HP:0100646) | 1.95369626 |
123 | Abnormality of the peritoneum (HP:0002585) | 1.95095345 |
124 | Nephritis (HP:0000123) | 1.94049278 |
125 | Abnormal platelet volume (HP:0011876) | 1.93873251 |
126 | Spondylolisthesis (HP:0003302) | 1.93798065 |
127 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.92154305 |
128 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.91930920 |
129 | B lymphocytopenia (HP:0010976) | 1.91825079 |
130 | Subacute progressive viral hepatitis (HP:0006572) | 1.90434997 |
131 | Arthralgia (HP:0002829) | 1.90353854 |
132 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.87672601 |
133 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.87672601 |
134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.87672601 |
135 | Progressive neurologic deterioration (HP:0002344) | 1.80208143 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TYK2 | 3.87008880 |
2 | IKBKE | 3.67977579 |
3 | MAP3K14 | 3.64727243 |
4 | TBK1 | 3.31233782 |
5 | TXK | 3.19705161 |
6 | MAP4K1 | 3.19496564 |
7 | JAK3 | 3.11524235 |
8 | KIT | 2.76682808 |
9 | IRAK4 | 2.76116911 |
10 | FGFR4 | 2.74674059 |
11 | JAK1 | 2.62366756 |
12 | IRAK3 | 2.52696275 |
13 | GRK7 | 2.37607180 |
14 | BLK | 2.25783203 |
15 | IKBKB | 2.04668233 |
16 | ERN1 | 2.00440778 |
17 | FGFR3 | 1.93025697 |
18 | ZAP70 | 1.74631008 |
19 | CSK | 1.68701422 |
20 | MAP3K13 | 1.68110675 |
21 | PRPF4B | 1.67719361 |
22 | IRAK2 | 1.64972892 |
23 | TAOK2 | 1.57501898 |
24 | TEC | 1.53331159 |
25 | TGFBR2 | 1.47589401 |
26 | CHUK | 1.43070803 |
27 | BTK | 1.41771179 |
28 | EPHA3 | 1.40115515 |
29 | MOS | 1.36993893 |
30 | FLT3 | 1.29961024 |
31 | CSF1R | 1.29464953 |
32 | RPS6KA4 | 1.26032167 |
33 | TAOK1 | 1.25388942 |
34 | PTK2B | 1.25249419 |
35 | NLK | 1.24497889 |
36 | HCK | 1.24088655 |
37 | SYK | 1.21469837 |
38 | HIPK2 | 1.19170583 |
39 | LCK | 1.18979591 |
40 | STK10 | 1.18410605 |
41 | NME2 | 1.18361676 |
42 | PBK | 1.13610014 |
43 | PIM2 | 1.13346420 |
44 | NEK9 | 1.12856545 |
45 | RIPK4 | 1.12805292 |
46 | TRPM7 | 1.09647926 |
47 | PIM1 | 1.08798300 |
48 | TAOK3 | 1.08659575 |
49 | DDR2 | 1.02137220 |
50 | LYN | 1.00698592 |
51 | MAP3K1 | 1.00416400 |
52 | ITK | 0.95462317 |
53 | ACVR1B | 0.94722513 |
54 | MATK | 0.94662046 |
55 | KDR | 0.92556449 |
56 | MAP3K11 | 0.91229746 |
57 | JAK2 | 0.91135051 |
58 | MST4 | 0.90534226 |
59 | RIPK1 | 0.90266539 |
60 | CDC42BPA | 0.88043695 |
61 | ZAK | 0.87825752 |
62 | EIF2AK2 | 0.86403493 |
63 | IRAK1 | 0.86101026 |
64 | PLK4 | 0.85528590 |
65 | EPHB1 | 0.81570142 |
66 | NUAK1 | 0.80734127 |
67 | STK4 | 0.75826690 |
68 | FRK | 0.75051065 |
69 | MAPK11 | 0.71458893 |
70 | MAP3K6 | 0.70840005 |
71 | BMPR2 | 0.70754308 |
72 | MAP2K3 | 0.70486425 |
73 | STK3 | 0.66202914 |
74 | TGFBR1 | 0.65487485 |
75 | PIK3CG | 0.63332414 |
76 | MARK3 | 0.62128473 |
77 | TIE1 | 0.61752295 |
78 | ERBB3 | 0.61733946 |
79 | SIK3 | 0.61580324 |
80 | GRK6 | 0.59263894 |
81 | SIK1 | 0.57737799 |
82 | CLK1 | 0.57661552 |
83 | CAMK1D | 0.56055822 |
84 | MAPK7 | 0.55972747 |
85 | BMX | 0.54571295 |
86 | TTN | 0.52074395 |
87 | EEF2K | 0.52065203 |
88 | YES1 | 0.48983500 |
89 | KSR2 | 0.48398940 |
90 | PTK6 | 0.47346277 |
91 | CAMKK2 | 0.47178803 |
92 | ABL1 | 0.47086461 |
93 | RPS6KA5 | 0.47011480 |
94 | PRKCD | 0.42784783 |
95 | MARK2 | 0.42689268 |
96 | PDK1 | 0.42370644 |
97 | RPS6KA6 | 0.42284235 |
98 | MAP3K2 | 0.41414525 |
99 | MAP3K3 | 0.41354976 |
100 | ADRBK2 | 0.39968070 |
101 | FGR | 0.39309137 |
102 | PRKG2 | 0.39124287 |
103 | TNK2 | 0.39104201 |
104 | PKN2 | 0.38970147 |
105 | EGFR | 0.38956108 |
106 | MELK | 0.38887656 |
107 | FES | 0.37537204 |
108 | PDGFRB | 0.37413876 |
109 | LRRK2 | 0.36987347 |
110 | CDK6 | 0.35803937 |
111 | CDK12 | 0.35467381 |
112 | MAP2K6 | 0.34707532 |
113 | PRKCQ | 0.34565446 |
114 | FYN | 0.33832931 |
115 | RPS6KB2 | 0.33433828 |
116 | SIK2 | 0.33284907 |
117 | IGF1R | 0.32958288 |
118 | DYRK3 | 0.31607021 |
119 | CDK9 | 0.31134523 |
120 | MAP3K5 | 0.29811414 |
121 | CDK4 | 0.29535333 |
122 | GRK1 | 0.29373741 |
123 | MAPKAPK2 | 0.28827332 |
124 | PRKCH | 0.27228298 |
125 | ATR | 0.27153862 |
126 | STK24 | 0.26826170 |
127 | KSR1 | 0.26647656 |
128 | FER | 0.26061824 |
129 | PDPK1 | 0.24737728 |
130 | PRKD2 | 0.23339358 |
131 | RAF1 | 0.22780972 |
132 | INSR | 0.21488678 |
133 | TESK2 | 0.21243641 |
134 | GRK5 | 0.19637197 |
135 | SGK3 | 0.19292839 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.91300870 |
2 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.81862404 |
3 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.81267576 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.74598818 |
5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.73125433 |
6 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.65515768 |
7 | * Measles_Homo sapiens_hsa05162 | 2.65205944 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.47210260 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.46390166 |
10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.42220351 |
11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.42171701 |
12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.40582958 |
13 | * Herpes simplex infection_Homo sapiens_hsa05168 | 2.08725378 |
14 | * Influenza A_Homo sapiens_hsa05164 | 2.06198215 |
15 | Malaria_Homo sapiens_hsa05144 | 2.06081348 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.03400909 |
17 | Asthma_Homo sapiens_hsa05310 | 1.99247343 |
18 | Legionellosis_Homo sapiens_hsa05134 | 1.96291788 |
19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87594912 |
20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.84951830 |
21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82640601 |
22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.82302845 |
23 | Pertussis_Homo sapiens_hsa05133 | 1.81895282 |
24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.67807023 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59914022 |
26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56806288 |
27 | Tuberculosis_Homo sapiens_hsa05152 | 1.52163466 |
28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49616527 |
29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47312082 |
30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47139820 |
31 | * Hepatitis C_Homo sapiens_hsa05160 | 1.34596870 |
32 | Apoptosis_Homo sapiens_hsa04210 | 1.31417598 |
33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30872442 |
34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.28511192 |
35 | * Hepatitis B_Homo sapiens_hsa05161 | 1.25479245 |
36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23284075 |
37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22301109 |
38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17103682 |
39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.15945924 |
40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12002774 |
41 | Salmonella infection_Homo sapiens_hsa05132 | 1.09721182 |
42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07764750 |
43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07651345 |
44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05082651 |
45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02522813 |
46 | Shigellosis_Homo sapiens_hsa05131 | 0.98336670 |
47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92441453 |
48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91546299 |
49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89760642 |
50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87754583 |
51 | Lysosome_Homo sapiens_hsa04142 | 0.86472939 |
52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79553923 |
53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77770651 |
54 | Phagosome_Homo sapiens_hsa04145 | 0.77164254 |
55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.75694981 |
56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75083292 |
57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70656395 |
58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68821936 |
59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66822294 |
60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66751462 |
61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63967229 |
62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63277669 |
63 | Amoebiasis_Homo sapiens_hsa05146 | 0.62599412 |
64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60192728 |
65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60004790 |
66 | ABC transporters_Homo sapiens_hsa02010 | 0.59396674 |
67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57923246 |
68 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57378461 |
69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56871940 |
70 | Bladder cancer_Homo sapiens_hsa05219 | 0.55574309 |
71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55546154 |
72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54208953 |
73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52715411 |
74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52435288 |
75 | Platelet activation_Homo sapiens_hsa04611 | 0.50923720 |
76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50461757 |
77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48408995 |
78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48387668 |
79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47687557 |
80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47321872 |
81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45301422 |
82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44139868 |
83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40714525 |
84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39377031 |
85 | Insulin resistance_Homo sapiens_hsa04931 | 0.38341972 |
86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38009819 |
87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37854312 |
88 | Endocytosis_Homo sapiens_hsa04144 | 0.37116303 |
89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36508738 |
90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35264110 |
91 | Peroxisome_Homo sapiens_hsa04146 | 0.34987962 |
92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34443490 |
93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34093505 |
94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32403988 |
95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31387593 |
96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31083369 |
97 | Adherens junction_Homo sapiens_hsa04520 | 0.30897236 |
98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30667189 |
99 | Prostate cancer_Homo sapiens_hsa05215 | 0.28877544 |
100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26429585 |
101 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.25899472 |
102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25392624 |
103 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.24103097 |
104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23124467 |
105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.23018750 |
106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22892844 |
107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22713427 |
108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22489803 |
109 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22400375 |
110 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.21992971 |
111 | Base excision repair_Homo sapiens_hsa03410 | 0.21726600 |
112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21694206 |
113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.21513992 |
114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.21066505 |
115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20264498 |
116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20073910 |
117 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.19782433 |
118 | Prion diseases_Homo sapiens_hsa05020 | 0.19740820 |
119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.19675670 |
120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18741889 |
121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.18683834 |
122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.16837323 |
123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.14309762 |
124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.12588817 |